Novavax - Vergessene Aktie feiert ein Comeback. Gute Chancen dank aktueller Nachrichtenlage (Seite 2)

[MP031949]

Hinzufügen, BTC, auch Krebs kam in der Diskussion und Novavax mit Partnern, will sich auch hier beteiligen, forschen und entwickeln....gute Perspektive!

[BTC123]

Aus der gestrigen JEFFRIES Konferenz:

Wie ich aus der gestrigen Konferenz verstanden habe, ist die Anwendung von Matrix-M nicht nur auf COVID und Grippe beschränkt. Es handelt sich wirklich um einen dynamischen Wirkverstärker, der die Wirksamkeit jeglicher Medikamente steigern kann. Daher könnten potenziell unbegrenzte Partnerschaften möglich sein, und der Deal mit Sanofi ist nur der Anfang. MatrixM ermöglicht es dem Körper, langfristige Antikörper zu aktivieren, die die Proteine des Impfstoffs angreifen. Dies ermöglicht eine langanhaltende immunologische Abwehr gegen Viren mit diesen Proteinspitzen.
Impfstoffe ohne diesen Wirkverstärker aktivieren eine Art von Antikörpern mit kurzfristigem Gedächtnis, was zu einer kürzeren Immunität führt als bei Impfstoffen mit Adjuvants
Daher kann dies mit allen proteinbasierten Impfstoffen gemischt werden.

[BTC123]

Is a Giant Short Squeeze Brewing in Novavax (NVAX) Stock?
Novavax is rising on both its latest COVID vaccine news and a short squeeze

19h ago · By Dana Blankenhorn, InvestorPlace Contributor

Vaccine maker Novavax (NVAX) is rising again.
It says it can meet FDA recommendations for a new Covid-19 vaccine in September.
There’s also a short squeeze developing.

https://investorplace.com/2024/06/is-a-giant-short-squeeze-b…

[BTC123]

CORONAVIRUS
Taylor Swift spreads Covid: thousand of fans fall ill after Madrid and Paris concerts
More than just the music was viral as Taylor Swift concerts in Madrid and Paris ended with thousands of fans ill with Covid
John McAulay
Photo: EFE
Barcelona. Thursday, 6 June 2024. 23:11
Reading time: 3 minutes

https://www.elnacional.cat/en/news/taylor-swift-spreads-covi…

[BTC123]

Largest inflow of bullish volume EVER. We didn’t even see volume like this during a global pandemic. Idk what the price will be tomorrow, or next week, but I’m confident this is still a multibagger from here.

[rexe05351]

Antwort auf Beitrag Nr.: 75.906.690 von BTC123 am 07.06.24 09:32:40

Ja! Das meine ich

[BTC123]

Novavax, With A 369% Gain, Reverses Bullish Gains After Key FDA Move

ALLISON GATLIN04:15 PM ET 06/06/2024
Novavax (NVAX) stock zipped higher Thursday — and then gave it all up — after the Food and Drug Administration set a potential approval date for its Covid vaccine in April.

In a filing with the Securities and Exchange Commission, Novavax said the FDA said it completed its filing review of the final portion of its request for approval. The agency is set to make its decision in April 2025.

The news initially sent Novavax stock as high as 13%. But Novavax shares closed down 6.8% at 19.56.

On Wednesday, Novavax said it plans to launch an updated booster to target the JN.1 variant, in line with the FDA Vaccines and Related Biological Products Advisory Committee's recommendation. Pfizer (PFE) and Moderna (MRNA) are also planning to prepare JN.1-focused boosters.

Novavax stock has been on a tear recently, surging 369% from dollar-stock status on May 9 to the closing price of 20.97 on Wednesday. Shares now have a perfect IBD Digital Relative Strength Rating of 99 and opened at their highest point since November 2022. The RS Rating is a 1-99 measure of a stock's 12-month performance.

Novavax Stock: Reversing Its Fortunes
Novavax's Covid vaccine has faced a number of setbacks over the years. The vaccine is based on protein technology, which is appealing to people hesitant to use the newer messenger RNA-based shots from Pfizer with partner BioNTech (BNTX) and Moderna.

But the Novavax Covid vaccine has never been officially approved. Instead, the company has racked up sales under an emergency use authorization. Last September, the FDA approved updated boosters from Pfizer and Moderna, but didn't authorize Novavax's shot until October.

Recent news, though, has set Novavax stock on a sprint. Shares skyrocketed more than 125% on May 10 after the company inked a licensing deal with Sanofi (SNY) for its Covid vaccine. Sanofi will pay Novavax $500 million up front. Milestone, regulatory and other payments could add $700 million.

The companies also agreed to co-develop a Covid/flu vaccine. Sanofi will co-commercialize it worldwide.

Since then. Novavax stock has continued climbing. Shares easily retook their 50-day and 200-day moving averages, MarketSurge shows. Notably, Novavax shares now have an improved Composite Rating of 89, putting their technical and fundamental performance in the leading 11% of all stocks.

Follow Allison Gatlin on X, the platform formerly known as Twitter, at @IBD_AGatlin.

YOU MAY ALSO LIKE:

Madrigal, 89bio Tumble After Lilly's Weight-Loss Drug Tackles MASH

Viking Therapeutics Stock Crumbles Despite Potential 'Best-In-Class' Liver Disease Drug

Find The Best Long-Term Investments With IBD Long-Term Leaders

Want To Get Quick Profits And Avoid Big Losses? Try SwingTrader

Learn How To Time The Market With IBD's ETF Market Strategy


RELATED NEWS
Moderna stock
Moderna Wins FDA Approval For Second-Ever Product; Why Its RSV Vaccine Could Dominate Pfizer, GSK
5/31/2024 The FDA approved Moderna's RSV vaccine, allowing the biotech to launch its second-ever product. But Moderna stock retreated.

Is Moderna Stock A Buy As The U.S. Government Mulls Its Bird Flu Vaccine?
The U.S. Is Close To Bankrolling Moderna's Bird Flu Vaccine As Third Dairy Worker Tests Positive
Option Trade On Volatile Moderna Stock Could Return 28% By Mid-July
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Is Novavax Stock A Buy After Nearly Tripling On $1.3 Billion Sanofi Deal?
Stocks To Watch: Moderna Sees Relative Strength Rating Rise To 92
Moderna Tumbles After The FDA Throws A Curveball On Its Second Product
Biotech Rockets 125% On Sanofi Covid Vaccine Agreement

https://www.investors.com/news/technology/novavax-stock-fda-…

[Another-earth]

Investierte die richtig Geld verdienen, haben nicht das Verlangen noch die Zeit hier zu Posen, oder besser gesagt zu prollen

[BTC123]

Antwort auf Beitrag Nr.: 75.906.033 von Another-earth am 07.06.24 08:24:10

Ich sehe doch meinen Ausführungskurs

[BTC123]

Antwort auf Beitrag Nr.: 75.906.006 von rexe05351 am 07.06.24 08:20:59

Du meinst ich bin dumm oder? ICh habe über 2 Jahre DCA betrieben und bin auch schon mit den Aktien im Plus.